These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23873336)

  • 1. Incidence and aetiology of renal phosphate loss in patients with hypophosphatemia in the intensive care unit.
    Bech A; Blans M; Telting D; de Boer H
    Intensive Care Med; 2013 Oct; 39(10):1785-91. PubMed ID: 23873336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of renal phosphate loss in liver resection-associated hypophosphatemia.
    Nafidi O; Lapointe RW; Lepage R; Kumar R; D'Amour P
    Ann Surg; 2009 May; 249(5):824-7. PubMed ID: 19387319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients.
    Evenepoel P; Naesens M; Claes K; Kuypers D; Vanrenterghem Y
    Am J Transplant; 2007 May; 7(5):1193-200. PubMed ID: 17359508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
    Bhan I; Shah A; Holmes J; Isakova T; Gutierrez O; Burnett SM; Jüppner H; Wolf M
    Kidney Int; 2006 Oct; 70(8):1486-94. PubMed ID: 16941023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic resection-related hypophosphatemia is of renal origin as manifested by isolated hyperphosphaturia.
    Salem RR; Tray K
    Ann Surg; 2005 Feb; 241(2):343-8. PubMed ID: 15650646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphate supplementation for hypophosphatemia during continuous renal replacement therapy in adults.
    Song YH; Seo EH; Yoo YS; Jo YI
    Ren Fail; 2019 Nov; 41(1):72-79. PubMed ID: 30909778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 23 in hypophosphataemic HIV-positive adults on tenofovir.
    Bech A; Van Bentum P; Nabbe K; Gisolf J; Richter C; De Boer H
    HIV Med; 2012 Oct; 13(9):558-63. PubMed ID: 22462533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective multicenter study to describe the prevalence, outcomes, and management of phosphate disorders in intensive care patients: Study protocol for part B of the international GUTPHOS study.
    Melchers M; Kouw IWK; Arabi YM; Casaer MP; Cotoia A; Gunst J; Malbrain MLNG; Schaller SJ; Starkopf J; Rehal MS; Blaser AR; van Zanten ARH
    Clin Nutr ESPEN; 2024 Oct; 63():681-687. PubMed ID: 39069259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperparathyroidism and increased fractional excretion of phosphate predict allograft loss in long-term kidney transplant recipients.
    Prakobsuk S; Sirilak S; Vipattawat K; Taweesedt PT; Sumethkul V; Kantachuvesiri S; Disthabanchong S
    Clin Exp Nephrol; 2017 Oct; 21(5):926-931. PubMed ID: 27981393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypophosphatemia in acute liver failure of a broad range of etiologies is associated with phosphaturia without kidney damage or phosphatonin elevation.
    Zechner C; Adams-Huet B; Gregory B; Neyra JA; Rule JA; Li X; Rakela J; Moe OW; Lee WM;
    Transl Res; 2021 Dec; 238():1-11. PubMed ID: 34298149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated fibroblast growth factor 23 levels as a cause of early post-renal transplantation hypophosphatemia.
    Han SY; Hwang EA; Park SB; Kim HC; Kim HT
    Transplant Proc; 2012 Apr; 44(3):657-60. PubMed ID: 22483462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The occurrence of hypophosphatemia and its prognostic value in intensive care unit patients].
    Fu JH; Zang B
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Jan; 24(1):29-32. PubMed ID: 22248748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypophosphatemia on the intensive care unit: individualized phosphate replacement based on serum levels and distribution volume.
    Bech A; Blans M; Raaijmakers M; Mulkens C; Telting D; de Boer H
    J Crit Care; 2013 Oct; 28(5):838-43. PubMed ID: 23642477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of hypophosphatemia in critical illness: A multicentre, retrospective cohort study.
    Attokaran AG; White KC; Doola R; McIlroy P; Senthuran S; Luke S; Garrett P; Tabah A; Shekar K; Edwards F; White H; McCullough JP; Hurford R; Clement P; Laupland KB; Ramanan M;
    Anaesth Crit Care Pain Med; 2024 Oct; 43(5):101410. PubMed ID: 39089453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.
    Evenepoel P; Meijers B; Viaene L; Bammens B; Claes K; Kuypers D; Vanderschueren D; Vanrenterghem Y
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1268-76. PubMed ID: 20448073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral phosphate supplementation corrects hypophosphatemia and normalizes plasma FGF23 and 25-hydroxyvitamin D3 levels in women with chronic metabolic acidosis.
    Domrongkitchaiporn S; Disthabanchong S; Cheawchanthanakij R; Niticharoenpong K; Stitchantrakul W; Charoenphandhu N; Krishnamra N
    Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):105-12. PubMed ID: 19449283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia.
    Charron T; Bernard F; Skrobik Y; Simoneau N; Gagnon N; Leblanc M
    Intensive Care Med; 2003 Aug; 29(8):1273-8. PubMed ID: 12845429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cinacalcet in the management of tumor-induced osteomalacia.
    Geller JL; Khosravi A; Kelly MH; Riminucci M; Adams JS; Collins MT
    J Bone Miner Res; 2007 Jun; 22(6):931-7. PubMed ID: 17352646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation.
    Pande S; Ritter CS; Rothstein M; Wiesen K; Vassiliadis J; Kumar R; Schiavi SC; Slatapolsky E; Brown AJ
    Nephron Physiol; 2006; 104(1):p23-32. PubMed ID: 16691036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.